HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kim De Veirman Selected Research

Pargyline (Pargyline Hydrochloride)

2/2022Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kim De Veirman Research Topics

Disease

18Multiple Myeloma
02/2022 - 01/2013
17Neoplasms (Cancer)
02/2022 - 01/2014
3Neoplasm Metastasis (Metastasis)
11/2019 - 06/2014
2Lymphoma (Lymphomas)
11/2019 - 01/2019
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2019 - 01/2019
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2019 - 01/2019
2Inflammation (Inflammations)
10/2017 - 12/2015
1Hypoxia (Hypoxemia)
02/2022
1Residual Neoplasm
01/2021
1Bone Resorption
11/2020
1Hematologic Neoplasms (Hematological Malignancy)
11/2019
1Disease Progression
01/2019
1Bone Diseases (Bone Disease)
11/2018
1Drug-Related Side Effects and Adverse Reactions
12/2013

Drug/Important Bio-Agent (IBA)

6Bortezomib (Velcade)FDA Link
02/2022 - 10/2017
5CytokinesIBA
10/2017 - 01/2013
4Pharmaceutical PreparationsIBA
11/2019 - 01/2018
3Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2018
3Radioisotopes (Radionuclides)IBA
01/2022 - 01/2021
3Single-Domain AntibodiesIBA
01/2022 - 01/2021
3Histone Deacetylase InhibitorsIBA
01/2018 - 05/2013
2Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
11/2019 - 11/2018
2venetoclaxIBA
11/2019 - 01/2019
2Anaphase-Promoting Complex-CyclosomeIBA
01/2019 - 01/2016
2VorinostatFDA Link
12/2013 - 05/2013
1Oxidoreductases (Dehydrogenase)IBA
02/2022
1delta-1-pyrroline-5-carboxylateIBA
02/2022
1Proline (L-Proline)FDA Link
02/2022
1Pargyline (Pargyline Hydrochloride)FDA Link
02/2022
1ParaproteinsIBA
01/2022
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Complement C3a (Complement 3a)IBA
05/2021
1Actinium-225IBA
01/2021
1Proteasome InhibitorsIBA
11/2020
1Phosphotransferases (Kinase)IBA
11/2019
11- (6- (3,5- dichloro- 4- hydroxyphenyl)- 4- ((4- ((dimethylamino)methyl)cyclohexyl)amino)- 1,5- naphthyridin- 3- yl)ethanoneIBA
11/2019
1CaspasesIBA
11/2019
1Axl Receptor Tyrosine KinaseIBA
11/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1GW 4869IBA
11/2018
1Transcription Factors (Transcription Factor)IBA
04/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2018
1MP0250IBA
03/2018
1Biological ProductsIBA
01/2018
1ChromatinIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1trametinibIBA
01/2018
1EnzymesIBA
01/2018
1MethyltransferasesIBA
01/2018
1A-Form DNA (A-DNA)IBA
01/2018
1S100 Proteins (S 100 Protein)IBA
10/2017
1Calgranulin BIBA
10/2017
1ABR-238901IBA
10/2017
1Fluorouracil (Carac)FDA LinkGeneric
04/2015
1AntibodiesIBA
04/2015
1ChemokinesIBA
06/2014
1Histone Deacetylases (Histone Deacetylase)IBA
05/2013

Therapy/Procedure

6Therapeutics
02/2022 - 01/2018
1Immunotherapy
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022
1Computer-Assisted Surgery (Image Guided Surgery)
01/2022
1Precision Medicine
01/2022
1Drug Therapy (Chemotherapy)
11/2019